Stocks · Korea
491000
KOSDAQ
LivsMed
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+27.45%
1M+15.02%
3M+11.82%
6M-45.44%
YTD-28.41%
52W high95,900원
52W low27,100원
From 52W high-60.06%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2025 | 512억 | -226억 | -229억 | -44.2% |
| Quarterly | ||||
| 2026 1Q | 103억 | -84억 | -59억 | -81.5% |
Company
Address: 경기도 성남시 분당구 판교로 700 분당테크노파크 디동 304호
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 큐리옥스바이오시스템즈 | 1.0조 | — | 19.20 | +22.31% |
| 에스디바이오센서 | 8,271억 | — | 0.35 | +10.84% |
| 디아이 | 1.2조 | 211.99 | 6.61 | +36.45% |
| 인바디 | 7,158억 | 21.91 | 2.23 | -9.90% |
| 클래시스 | 2.0조 | 15.22 | 3.62 | -3.15% |
| 케이씨 | 5,207억 | 11.97 | 0.61 | +28.40% |
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-06-22[기재정정]주요사항보고서(유형자산양수결정) Major
- 2026-05-15분기보고서 (2026.03)
- 2026-05-13[첨부정정]주요사항보고서(유형자산양수결정) Major
- 2026-05-13주요사항보고서(유형자산양수결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.